Julie Nangia Explains Scalp Cooling Devices for Chemotherapy Induced Hair Loss

Video

Julie Nangia explains the process for the Orbis Paxman Hair Loss Prevention System.

Julie Nangia, MD, Baylor College of Medicine, explains the process for scalp cooling devices, in particular the Orbis Paxman Hair Loss Prevention System.

The device is used to prevent chemotherapy-induced hair loss. It is worn by the patient before, for the duration of, and after chemotherapy. The device is fitted and sized to the patient and starts with a cold sensation that the patient gradually acclimates to. In recent trial that Nangia presented at the 2016 Annual Meeting of the San Antonio Breast Cancer Symposium, many of the patients reported on a comfort scale that the device was “reasonably” comfortable, according to Nangia. However, patients who have a history of migraines and headaches will not tolerate the device well.

Recent Videos
Anne M. Reb, PhD, NP, discussing a nurse-led intervention for fear of cancer recurrence.
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.